Jordan J. Green

Herschel L. Seder Professor of Biomedical Engineering
Johns Hopkins University School of Medicine

​

Dr. Jordan J. Green is the Herschel L. Seder Professor of Biomedical Engineering, Ophthalmology, Neurosurgery, Oncology, Materials Science & Engineering, and Chemical & Biomolecular Engineering at the Johns Hopkins University. He is also an inaugural JHU Provost Fellow for Public Engagement. Dr. Green serves as the Vice Chair for Research and Translation in Biomedical Engineering and is the former Director of the Biomedical Engineering Undergraduate Program at JHU. Dr. Green is also the Co-Director of the Johns Hopkins Translational Immuno Engineering Center (NIH-funded National Center for Biomedical Imaging & Bioengineering) and the Associate Director of the Translational Tissue Engineering Center at JHU. He received his B.S. in Chemical Engineering and in Biomedical Engineering from Carnegie Mellon University in 2003 and completed his Ph.D. in Biological Engineering from MIT in 2007. Subsequently, Dr. Green was a postdoctoral associate at MIT from 2007-2008 with Institute Professor Bob Langer. Dr. Green was the founding CEO of the biotech company AsclepiX Therapeutics, a company that is now in clinical trials for a new peptide-based treatment for age-related macular degeneration. He also co-founded and serves on the board of four other biotechnology companies. He is an elected Fellow of the National Academy of Inventors, the Biomedical Engineering Society, the American Institute for Medical and Biological Engineering, and the Controlled Release Society. He is also an Associate Editor at Science Advances and a standing member of the NIH Drug and Biologic Therapeutic Delivery (DBTD) study section. His work has resulted in the publication of over 195 scientific papers, 90 issued or pending patents, and 145 invited talks, and he has received numerous awards including the AIChE Colburn Award, the BMES Rita Schaffer Award, the Presidential Early Career Award for Scientists and Engineers, Popular Science’s Brilliant Ten, and was a National Academy of Medicine Emerging Leader Scholar in Health & Medicine. Dr. Green’s research focuses on the design of biotechnologies for cellular engineering. He and his lab design and synthesize new biomaterials and nanotechnology systems that can deliver biomolecules such as nucleic acids, peptides, proteins, and small molecules specifically to various cell types, including cancer cells, immune cells, and stem cells. His lab works to create innovative technologies and therapeutics that can directly benefit human health.

 

Speech title & Synopsis

Polymeric Particles for Immunomodulation

.